NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. TLSA ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today announced for the first time, quantitative data showing improvement in…
#pet #tarunsinghal #mbbs #petimagingprogram #harvardmedicalschool #expandedaccess #isppea #f18pbr06pet #edss #gabrielecerrone
Continue reading...